What Are You Thinking About Investing In Axsome Therapeutics Inc. (NASDAQ: AXSM) Stock?

view original post

Axsome Therapeutics Inc. (NASDAQ:AXSM) traded at $30.50 at close of the session on Monday, 04/25/22, made a downward move of -21.99% on its previous day’s price.

Looking at the stock we see that its previous close was $39.10 and the beta (5Y monthly) reads 2.22 with the day’s price range being $28.8801 – $31.75. In terms of its 52-week price range, AXSM has a high of $74.10 and a low of $19.38. The company’s stock has lost about -15.23% over that past 30 days.

Axsome Therapeutics Inc. has a market cap of $1.29 billion and is expected to release its quarterly earnings report on Feb 28, 2022 – Mar 04, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$1.03, with the EPS growth for the year raised at -$3.59 for 2021 and -$3.9 for next year. These figures represent -29.60% and -8.60% growth in EPS for the two years respectively.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AXSM stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 14 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Axsome Therapeutics Inc. (AXSM) stock as a Hold, while 12 rate it as a Buy. 0 analyst(s) rate it as overweight while 1 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is -24.58% off its SMA20 and -12.37% from its 50-day simple moving average. The RSI (14) is pointing at 38.96 while the volatility over the past week is 9.46% and jumps to 8.13% over the past one month. The beta value is 2.42, while the average true range (ATR) is currently pointing at 3.79. The average price target for the stock over the next 12 months is $87.06, with the estimates having a low of $29.00 and a high of $180.00. These price ends are 4.92% and -490.16% off the current price level respectively, although investors could be excited at the prospect of a -127.87% if the AXSM share price touches on the median price of $69.50.

Let’s briefly compare Axsome Therapeutics Inc. (AXSM) stock to its peers. We find that current price change of -21.99% and -48.05% over the past 12 months for AXSM competes that of Pieris Pharmaceuticals Inc. (PIRS), which has seen its stock price rise 1.94% in the last trading session and was 30.58% over the last one year. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at 0.57% and 0.70%, respectively, at close of the trading.

Coming back to Axsome Therapeutics Inc. (NASDAQ:AXSM), we note that the average 3-month trading volume was 915.78K. Current shares outstanding are 37.77 million.

The insiders hold 0.50% of the company’s shares while institutions hold 49.20%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -19.27% down in year-to-date price movement.